Consilium Strategic Communications was formed in 2013 following a management buyout, led by Mary-Jane Elliott, from M:Communications.
Mary-Jane has more than 20 years of healthcare experience from leading communications agencies and the pharmaceutical industry and is an expert in financial, corporate, investor and scientific communications.
Prior to founding Consilium, Mary-Jane established and led M:Communications’ successful international healthcare practice where she advised public and private companies internationally across all sub-sectors of healthcare and including some of the sector’s leading industry bodies. She has extensive experience including advising on a wide range of high profile IPOs, secondary fundraisings, private equity placements, M&A transactions, crisis communications and clinical data and product launches. Mary-Jane also spent six years at WPP’s Financial PR advisory firm, Buchanan Communications, as a Partner.
Prior to moving to the City, Mary-Jane worked at PowderJect Pharmaceuticals plc from 1997-2003 as a scientist and latterly as a PR/IR executive. She was previously a scientist with Bell Laboratories Inc., in Madison, Wisconsin, US. Mary-Jane has a BSc (Hons) in BioMedical Sciences.